Gelatin Market

[237 Pages Report] The market for gelatin is estimated at USD 4.0 billion in 2024; it is projected to grow at a CAGR of 6.9% to reach USD 5.6 billion by 2029.  The pharmaceutical grade of gelatin is one of the major drivers of the growth in the gelatin market. Key players, such as Tessenderlo Group and Gelita AG, rely heavily on research and development to support innovation and market position. In May 2022, Rousselot launched Quali-Pure HGP 2000, an endotoxin-controlled gelatin for vaccines and wound healing. In 2021, Rousselot extended its range of purified, pharmaceutical-grade, modified gelatins with X-Pure GelDAT. It grows because of its wide range of uses in food and beverages, medicine, and cosmetics. Collagen-derived protein gelatin has applications as a thickening, stabilizing, and gelling agent and finds an application in pharmaceutical purposes for capsules and tablets. Its application in cosmetics is realized owing to its film-forming and moisturizing properties. Technological advancements in the methods of production and the development of alternative gelatins make the market grow because of dietary and ethical purposes.

To know about the assumptions considered for the study, Request for Free Sample Report

To know about the assumptions considered for the study, download the pdf brochure

Driver: Increasing use of gelatin in biomedical applications

Gelatin acts as a scaffold to the vascular cells in replacement of the blood vessels lost due to coronal heart disease, rheumatic heart disease, and myocardial infarction; it is also used as a carrier for the growth factors and cells used in repairing cardiac tissues post-ML. It means that gelatin is also used as a dressing material for serious burns and chronic wounds, such as diabetic foot ulcers and venous leg ulcers, because it is compatible with the skin of humans. This makes this property sufficient to be used in zinc paste binders for wound dressing. Gelatin-based blood-stanching sponges enjoy the advantage of being effective at healing wounds from thoracic surgeries and are used in repairing defects of the pleura from thoracotomies, thoracoplasties, and extrapleural procedures because of the regenerating tissues' growth such as the pleura and fibrous tissues, which grow when the gelatin implants gradually resorb; Gelatin sponges are known to find surgical and dental uses, and, what's more, it can even be used as a plasma substitute when there is a loss of blood. As a result of the rise in chronic diseases, there would probably be an increase in demand for gelatin-based products.

Research in the present is focused on injectable gelatin hydrogels for the acceleration of skin wound healing. These hydrogels maintain a moist healing environment and protect the wound from desiccation, thus bringing comfort to patients by means of cooling effects and non-adhesiveness to tissue. Increasing rates of CVD, a reduced number of organ donors, and the possible immune complications after a heart replacement may stimulate interest in innovative cardiac reparation solutions using tissue engineering and regenerative medicine. This is likely to further increase the demand for gelatin in these applications.

Restraint: Cultural restrictions

Gelatin finds application in many food, pharmaceutical, and nutraceutical industries. It is one of the important ingredients in quite a large number of foodstuffs used for making hard and soft capsules and as a protein Supplement. The source of gelatin is animal collagen, derived from cattle, pigs, fish, and poultry bones, hides, and hooves. This poses a problem to the people with dietary restrictions who avoid animal products. For example, pork and its derivatives are tabooed in Middle Eastern and Muslim cultures; therefore, there would be a local demand for gelatin of bovine origin and bearing the halal certification. Hence, pork-derived gelatin demand would be close to nil in those regions. Similarly, in India, where cattle products are culturally taboo for use by Hindus, pork-derived gelatin tends to find wider usage. Moreover, kosher certified products are also sought after by the Jewish community since their kosher laws also avoid pork consumption. These cultural and regional factors can act as barriers to the growth in the gelatin market.

Opportunity: Changing lifestyles and food habits

Changing lifestyles, food habits, and the adoption of Western dietary preferences have fueled demand for functional ingredients in food products, greatly contributing to boosting the growth in developing economies. Asia Pacific, South Africa, the Middle East, South America, and Eastern Europe region presents huge opportunities for the gelatin market. For example, in October 2022, PB Leiner added three new products—Dsolve B, Dsolve P, and Dsolve XTRA—to its gelwoRx Dsolve pharmaceutical portfolio. On one hand, Dsolve P is sourced from pig skin and Dsolve B from beef hide to ensure low cross-linking and ultra-rapid dissolution in soft capsules. On the other hand, Dsolve XTRA from bovine bone provides ultra-high performance over the former two products. Moreover, in December 2020, Gelita AG acquired 65% of the shares in the Turkish manufacturing company of gelatin, Sellel. Such a joint venture will contribute to meeting the increased demand for gelatin, mainly halal bovine gelatin, highly requested not only by Islamic countries but also by a large part of Asia.

Challenge:Animal borne diseases

The pharmaceutical gelatin market relies on animal-derived products and thus faces significant risks arising from the higher incidence of various animal-borne diseases all over the world. A good example would be the case of foot-and-mouth disease - an infection that has a very fast mode of transmission and affects cattle. It can spread rampantly and result in lots of economic losses. The 2001 UK outbreak led to more than six million cows and sheep being culled to contain the disease. Similarly, the development of BSE—bovine spongiform encephalopathy—which is transmitted from cattle to humans, has also compelled strict laws with respect to treating bovine-derived products.

In August 2018, China reported the first outbreak of ASF, a highly contagious hemorrhagic disease, which killed close to 120 to 180 million hogs—roughly 40-50% of the country's pig population—in 2019. This huge loss greatly influenced the price of gelatin from an early 2019 USD 5.30-5.90 per kilogram to USD 7.60-8.20 per kilogram by September 2019 due to shortage of raw material supplies.

As of March 2022, ASF has killed over 33,000 pigs in Mizoram in India, causing more than USD 8 million worth of losses, approximately, for the outbreak in 2021. The event required the culling of 10,910 pigs to prevent further spreading and banned the importation of pigs from neighboring states and countries for about 17 months, from August 2020 to January 2022. The outbreak has caused a shortage in porcine raw materials, directly hitting production. These outbreaks are expected to continue pushing up raw material prices and scarcity, while consumers turn to alternative plant-based products to replace; this creates a challenge to market growth.

GELATIN MARKET ECOSYSTEM

Prominent companies in this market include well-established, financially stable manufacturers of gelatin. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include Darling Ingredients (US), Tessenderlo Group (Belgium), GELITA AG (Germany), Nitta Gelatin Inc. (Japan), LAPI GELATINE S.P.A. (Italy).

Based on applications, the pharmaceutical segment is estimated to grow at the significant CAGR during the studied period.

Consumers are increasingly turning toward healthy & nutritive pharmaceutical-grade products. The gelatin in the applications is majorly used in the form of hard gel capsule, soft gel capsule, and sponging agent. Hard gelatin capsules have several advantages that make them a reliable choice for pharmaceutical applications. They ensure secure containment of their contents and provide consistent performance. Some of the major advantages include fast release of drug, homogenous mixing of ingredients, and prevention from oxygen that leads to drug oxidation. Another advantage is that hard gelatin capsules are less expensive compared to the soft gelatin capsules because they demand less complicated machinery and fewer special ingredients.

The hard capsules segment will likely grow due to growing interest from biopharmaceuticals since the demand is on the rise for capsule dosage forms. For example, in May 2022, Lonza extended its Capsugel line with the introduction of TiO2-free white hard gelatin capsules.

The type A in the gelatin market is forecasted to register the most significant CAGR over the projected period.

Type A gelatin has been proposed and evaluated as a 3D matrix for reconstructing skin collagen's fibrillar pattern. Hence, cell-based gelatins developed skin dressings with very wide market usages. Consequently, Type A gelatin has the widest application in medical devices, pharmaceuticals, and cosmetic industries under various industries globally. This has further led the key players to develop a wide range of products within the category. Within the pharmaceutical industry itself, type A gelatin is redeveloped into nanospheres or nanoparticles or microspheres and then used as a drug delivery carrier. The key players in the market are Darling Ingredients, US, and Symatese stay ahead due to their contribution towards the global availability of Type A gelatin. For instance, in March 2023, Symrise announced the introduction of a new range of Diana food bioactives highlighting Type A gelatin as one of the key ingredients for Beauty from Within. It means that with all the investments increasing and new launches, demand for Type A gelatin keeps increasing from nutritional and health products.

The Asia Pacific region is anticipated to experience rapid growth between 2024 and 2029.

The demand for gelatin is growing in the region of Asia Pacific, driven by the rising demand from the pharmaceutical industry and changing consumer preference. According to the study by Torreya, the Chinese pharmaceuticals industry is projected to increase by 230% between the years 2017 and 2030, driven by government cost controls, aging population, and rising disposable incomes. The rise in demand for pharmaceutical gelatin in the region is also explained by the fact that pharmaceutical production in China is independent and regulatory policies remain dynamic. Some consuming countries of gelatin are China, India, and Japan, mainly due to large population size and consumption of non-traditional food types such as functional and convenience foods that use gelatin as a fortification and stabilizing agent.

Key Market Players 

Key Market Players in this include Darling Ingredients (US), Tessenderlo Group (Belgium), GELITA AG (Germany), Nitta Gelatin Inc. (Japan), Lapi Gelatine S.p.a. (Italy), India Gelatine & Chemicals Ltd. (India), Narmada Gelatines Limited (India), Nippi. Inc. (Japan), Weishardt (France), Trobas Gelatine B.V. (Netherlands), Sterling Biotech Ltd (India), Roxlor (US), Suheung (South Korea), Ewald-Gelatin GmbH (Germany), Geltech Co., Ltd (Korea).

Other players include Gelken (China), Kenney & Ross Limited (Canada), Jellice Gelatin & Collagen (Netherlands), Athos Collagen Pvt. Ltd (India), ITALGEL S.p.a. (Italy), Foodmate Co., Ltd (China), Xushang Gelatin Co., Ltd (China), ElNasr4Gelatin (Saudi Arabia), Boom Gelatin (China), Baotou Dongbao Bio-Tech Co., Ltd. (China).

These players in this market are focusing on increasing their presence through agreements and collaborations. These companies have a strong presence in North America, Asia Pacific, and Europe. They also have manufacturing facilities along with strong distribution networks across these regions.

Want to explore hidden markets that can drive new revenue in Gelatin Market?

Unlock Insights

Click on image to enlarge

Scope of the Report

:

This research report categorizes the gelatin market based on source, type, function and application, and region.

Gelatin Market:

By Source

• Bovine
• Porcine
• Marine
• Poultry
• Other Source

By Applications

• Food & beverages
  • Confectionary & bakery products
  • Beverages
  • Dairy products
  • Meat products
  • Other food products
• Pharmaceuticals
• Health & Nutrition
• Cosmetics & personal care products
• Animal feed

By Type

• Type A
• Type B

By Function

• Thickeners
• Stabilizers
• Gelling Agents
• Other Functions

By Region

• North America
• Europe
• Asia Pacific
• South America
• Rest of the World (RoW)

Recent Developments

• In March 2023, Darling Ingredients finalized the acquisition of Geloex (Brazil), a leading producer of gelatin and collagen, for about USD 1.2 billion. This purchase increases Darling's production capacity to 46,000 metric tons of gelatin and collagen each year and is projected to generate USD 75 million in EBITDA in 2023. With 17 facilities globally, Darling's health brand Rousselot serves as a major supplier of gelatin and collagen products from diverse sources, targeting the health and nutrition sector.
• In January 2022, Rousselot and TIBI are collaborating to develop gelatin-based treatments and their application in clinical environments. During this partnership, Rousselot shared insights on gelatin behavior in the institute's research and clinical trials, supplying TIBI with X-Pure modified gelatins, including X-Pure GelMA.
• In November 2022, PB Leiner, a subsidiary of Tessenderlo Group, introduced TEXTURA Tempo Ready, a texturizing gelatin solution designed for the food service sector. Packaged in small pouches, it is distributed to chefs via selected wholesalers. This product offers strong flavor, improved mouthfeel, and greater stability over time.
• In October 2022, PB Leiner expanded its gelwoRx Dsolve pharmaceutical line with three new products: Dsolve B, Dsolve P, and Dsolve XTRA. Dsolve P (derived from pig skin) and Dsolve B (from beef hide) are specifically designed to minimize cross-linking and ensure quick dissolution of soft capsules. Dsolve XTRA (made from bovine bone) is expected to outperform Dsolve, Dsolve P, and Dsolve B.
• In December 2021, Lapi Gelatine purchased Junca Gelatines, a company based in Spain, to enhance its industrial gelatin sector. This acquisition has bolstered Lapi's position in the gelatin market by supporting growth opportunities.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst